Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Oral Dis ; 2024 Apr 09.
Article in English | MEDLINE | ID: mdl-38591808

ABSTRACT

AIMS: To evaluate osteoradionecrosis (ORN) incidence in a cohort of patients undergoing tooth extraction (TE) before radiotherapy (RT) for head and neck cancers. METHODS: The study protocol was approved by the Ethics Committee of Università Cattolica del Sacro Cuore (ID-2132) and registered at clinicaltrials.gov (ID: NCT04009161). TE was performed in case of signs of pericoronitis, periapical lesions, restorative impossibility, severe periodontitis. ORN was defined as exposed bone at an unhealed post-extraction socket in the absence of oncological recurrence. The RT plans were reviewed, and each post-extractive socket was contoured to calculate the received radiation dose. RESULTS: In total, 156 patients with 610 TE were enrolled. The mean follow-up was 567 days. ORN was diagnosed in four patients (2.6% of patients and 0.7% of TE). Need for osteotomy and radiation dose at the extraction site were associated with ORN (OR for osteotomy: 21.9, 95% CI: 2.17-222.2, p = 0.009; OR for RT dose: 1.1, 95% CI: 1-1.15, p = 0.05). CONCLUSIONS: TE appears to be a significant risk factor for ORN, particularly when osteotomy is required, and post-extraction sockets receive a high RT dosage. This study proposes a decision-making algorithm for TE and outlines a straightforward surgical protocol.

2.
Clin Oral Investig ; 25(10): 5687-5697, 2021 Oct.
Article in English | MEDLINE | ID: mdl-33704571

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the postoperative course in patients undergoing oral mucosal biopsies, considering clinical and patient's perception variables potentially correlated to poor healing. SUBJECTS AND METHODS: Eighty patients underwent oral biopsies. All the variables connected with the surgery were recorded, and the harvested volume was calculated through image software (ImageJ, NIH, Betesda, USA). To evaluate the postoperative discomfort, the OHIP-14 and the numeric rating scale of pain (NRS) were administered at 6 h, 7 days and 21 days after biopsy. RESULTS: Six hours after the biopsy, 22 (OHIP-14 ≥ 20) and 24 (NRS ≥ 4) patients experienced a troublesome or painful healing, respectively. A significant statistical correlation between poor healing and high scores of NRS and OHIP was detected (Pearson's correlation test p < 0.05). Higher values of OHIP-14 were correlated to the type of lesion (OR = 1.165; p < 0.05), whereas high values of NRS were correlated to the use of systemic drugs (p < 0.05). No surgical variable had a significant statistical correlation with any of the outcomes. CONCLUSIONS: The clinical evaluation was correlated with the patient's perception of pain and discomfort. This finding could be suggestive of the fact that wound healing can be reliably monitored with the help of these tools. CLINICAL RELEVANCE: Patient perception can be a predictor of the healing of biopsied tissues.


Subject(s)
Mouth Mucosa , Outpatients , Biopsy , Humans , Oral Health , Perception , Quality of Life , Surveys and Questionnaires
3.
Clin Chem ; 27(8): 1385-7, 1981 Aug.
Article in English | MEDLINE | ID: mdl-6456089

ABSTRACT

In this quantitative assay, urinary urobilinogen is oxidized to urobilin with iodate in an acid medium, the pH is adjusted to 6 with sodium acetate, and the mixture is reacted with alcoholic HgCl2 solution, extracted with CHCl3, the measured spectrophotometrically at 513 nm. The artificial standards of previous methods have been replaced with crystalline stercobilin IX (commercially available), a urobilin closely related to the urinary urobilins. The reproducibility of the method, as assessed from 10 replicates of a single urine specimen to which urobilinogen was added, gave a coefficient of variation of 3.9%. Analytical recovery of urobilinogen added to urines was 90.4% (SD 14.5%). Bilirubin, biliverdin, mesobilirubin, coproporphyrin I, uroporphyrin I, and porphobilinogen do not interfere.


Subject(s)
Mercury , Urobilinogen/urine , Clinical Laboratory Techniques , Humans , Indicators and Reagents , Liver Diseases/diagnosis , Mercuric Chloride , Spectrophotometry/methods
4.
Am J Med Technol ; 47(9): 729-35, 1981 Sep.
Article in English | MEDLINE | ID: mdl-7304667

ABSTRACT

A strip test based on Ehrlich's reaction has improved specificity for urobilinogen in urine. Strip reactions are calibrated in mg/dl using a recently developed reference assay which is based on a mercuric chloride reaction and includes a crystalline reference standard. Strip reactions correlate well with the mercuric assay when the urine sample contains only urobilinogen. If a urine contains urobilin in addition to urobilinogen, the strip test gives slightly lower values than the reference assay. The strip test reacts only with urobilinogen but the reference assay measures urobilin as well as urobilinogen. Comparative data with both tests are included for normal and pathological urines. Reaction colors with the strip test have been characterized in L* a b* values, an international basis for color designation.


Subject(s)
Indicators and Reagents/standards , Reagent Strips/standards , Urobilinogen/urine , Calibration , Chlorides , Humans , Mercury/pharmacology , Reference Standards
5.
N Engl J Med ; 307(23): 1422-6, 1982 Dec 02.
Article in English | MEDLINE | ID: mdl-7133096

ABSTRACT

Antibodies to the insulin receptor are insulinomimetic in vitro, although they generally induce insulin resistance in vivo. We report the novel case of a patient who presented with fasting hypoglycemia as the sole manifestation of autoantibodies to the insulin receptor. Prednisone therapy (120 mg per day) produced a rise in fasting glucose to more than 100 mg per deciliter (6 mmol per liter) within 48 hours, although there was no detectable change in the titer of antireceptor antibodies. After 10 weeks of therapy, the titer of antireceptor antibodies had fallen approximately 100-fold, and prednisone could be discontinued without recurrence of hypoglycemia. This case demonstrates that antireceptor antibodies must be considered in the differential diagnosis of hypoglycemia, especially in patients with other manifestations of autoimmunity.


Subject(s)
Autoantibodies/analysis , Autoimmune Diseases/diagnosis , Hypoglycemia/diagnosis , Receptor, Insulin/immunology , Adipose Tissue/metabolism , Autoimmune Diseases/drug therapy , Blood Glucose/analysis , Diagnosis, Differential , Fasting , Female , Humans , Hypoglycemia/drug therapy , Hypoglycemia/etiology , Immunoglobulin G/analysis , Lipids/biosynthesis , Middle Aged , Prednisone/administration & dosage , Prednisone/pharmacology , Prednisone/therapeutic use
6.
Mod Treat ; 3(6): 1280-6, 1966 Nov.
Article in English | MEDLINE | ID: mdl-4380796
SELECTION OF CITATIONS
SEARCH DETAIL